About Diatech Pharmacogenetics
Diatech Pharmacogenetics is a Healthcare company based in Ancona (Italy) founded in 1994. Diagnostic kits for pharmacogenetic tests in oncology are provided. Diatech Pharmacogenetics offers products and services including Solid Tumor Kit and Blood Cancer Kit. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity is Diatech Pharmacogenetics srl.
Company details
Provider of diagnostic kits for pharmacogenetic tests. The companys test portfolio includes EasyPGX line of single-gene tests for cancer (using circulating DNA), Myriapod - an SNP panel for predicting adverse response to anticancer therapy, Easy line of kits that allow the qualitative detection of the main somatic mutations of the genes EGFR, KRAS, NRAS and BRAF by Real-Time PCR in association with a system of enrichment of the mutated allele, and the titan microsatellite instability test. The company is also developing the Leonid platform for transcript biomarker analysis of lung cancer.
- Headquarters Ancona, Italy
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website diatechpharmacogenetics.com
- Social LinkedIn X Facebook YouTube
- Legal Name Diatech Pharmacogenetics Srl
- InvestorsEuropean Union
& 3 more
Products & Services of Diatech Pharmacogenetics
Diatech Pharmacogenetics offers a comprehensive portfolio of products and services, including Solid Tumor Kit and Blood Cancer Kit.
Kits for pharmacogenetic testing in solid tumors
Kits for pharmacogenetic testing in blood cancer
Apps and channels of Diatech Pharmacogenetics
its YouTube channel Diatech Pharmacogenetics has 109 subscribers and 24 videos.
Videos from Diatech Pharmacogenetics
The most watched videos on Diatech Pharmacogenetics's YouTube channel, Diatech Pharmacogenetics (109 subscribers). Click a video to play it here.
More on Diatech Pharmacogenetics.
Funding Insights of Diatech Pharmacogenetics
- Total Rounds 4
- First Round $1.43M
(Jul 2015)
- Investors Count 4
All 4 funding rounds of Diatech Pharmacogenetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2023 | Private Equity Round | – | TA | – | |
| Jun 2021 | Private Equity Round | – | Alto Partners | – | |
| Dec 2016 | $1.8M | Grant | – | – | |
| Jul 2015 | $1.43M | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Diatech Pharmacogenetics
Diatech Pharmacogenetics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, TA Associates and Alto Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are invested in by private equity firm TA. | ta.com | Boston, United States | ||
| altopartners.it | ||||
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Diatech Pharmacogenetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Diatech Pharmacogenetics
10 people are tracked at Diatech Pharmacogenetics (4 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Edoardo Petrini | Head of Bioinformatics | Leadership |
Maura Menghi | Scientific Director | Leadership |
Oliva Alberti | CEO | Leadership |
Vincenzo Ciccone | CFO | Leadership |
Maria Rita Litterio | Brand marketing and corporate events assistant | Team |
Michela Romiti | Channel Partners Manager | Team |
Grit L. | Business Development Manager Export | Team |
Davide Ceriani | Global Sales Manager | Team |
Matteo Panfili | Marketing Manager | Team |
Francesco Cante | Sales Manager Italy | Team |
Complete people profiles for Diatech Pharmacogenetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Diatech Pharmacogenetics
3 dated milestones of Diatech Pharmacogenetics across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Diatech Pharmacogenetics is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Private Equity Round,.
Web traffic of Diatech Pharmacogenetics
The website of Diatech Pharmacogenetics (diatechpharmacogenetics.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 6% vs previous month
Websites whose visitors overlap most with Diatech Pharmacogenetics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
glioblastomamultiforme.it | glioblastomamultiforme.it | 100% | #3,929,899 | – | |
dairycare.com | dairycare.com | 96% | #9,737,309 | – | |
cancerbiomed.org | cancerbiomed.org | 88% | #988,861 | – | |
sperimentazionicliniche.it | sperimentazionicliniche.it | 67% | – | ||
sanita33.it | sanita33.it | 64% | #2,410,162 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Diatech Pharmacogenetics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Diatech Pharmacogenetics
Complete news archive for Diatech Pharmacogenetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diatech Pharmacogenetics
Diatech Pharmacogenetics was founded in 1994 and raised its 1st funding round 21 years after it was founded.
Diatech Pharmacogenetics is headquartered in Ancona, Italy. It is registered at Ancona, Marche, Italy.
Provider of diagnostic kits for pharmacogenetic tests. The companys test portfolio includes EasyPGX line of single-gene tests for cancer (using circulating DNA), Myriapod - an SNP panel for predicting adverse response to anticancer therapy, Easy line of kits that allow the qualitative detection of the main somatic mutations of the genes EGFR, KRAS, NRAS and BRAF by Real-Time PCR in association with a system of enrichment of the mutated allele, and the titan microsatellite instability test. The company is also developing the Leonid platform for transcript biomarker analysis of lung cancer.
Diatech Pharmacogenetics offers Solid Tumor Kit and Blood Cancer Kit.
Diatech Pharmacogenetics has 4 investors. Key investors include European Union, TA Associates, Alto Partners, and EIC Fund.
Diatech Pharmacogenetics operates through Diatech Pharmacogenetics Srl.